Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
70,784,540
-
Share change
-
+5,417,371
-
Total reported value
-
$242,767,740
-
Put/Call ratio
-
4.8%
-
Price per share
-
$3.43
-
Number of holders
-
105
-
Value change
-
+$18,948,500
-
Number of buys
-
44
-
Number of sells
-
42
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2021
As of 31 Mar 2021,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,784,540 shares.
The largest 10 holders included
NEA Management Company, LLC, BlackRock Inc., WASATCH ADVISORS INC, First Light Asset Management, LLC, VANGUARD GROUP INC, BVF INC/IL, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, Burrage Capital Management LLC, and Sectoral Asset Management Inc.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.